A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo

Journal of Bacteriology
Slade LoutetMiguel A Valvano

Abstract

Burkholderia cenocepacia is an important opportunistic pathogen of patients with cystic fibrosis. This bacterium is inherently resistant to a wide range of antimicrobial agents, including high concentrations of antimicrobial peptides. We hypothesized that the lipopolysaccharide (LPS) of B. cenocepacia is important for both virulence and resistance to antimicrobial peptides. We identified hldA and hldD genes in B. cenocepacia strain K56-2. These two genes encode enzymes involved in the modification of heptose sugars prior to their incorporation into the LPS core oligosaccharide. We constructed a mutant, SAL1, which was defective in expression of both hldA and hldD, and by performing complementation studies we confirmed that the functions encoded by both of these B. cenocepacia genes were needed for synthesis of a complete LPS core oligosaccharide. The LPS produced by SAL1 consisted of a short lipid A-core oligosaccharide and was devoid of O antigen. SAL1 was sensitive to the antimicrobial peptides polymyxin B, melittin, and human neutrophil peptide 1. In contrast, another B. cenocepacia mutant strain that produced complete lipid A-core oligosaccharide but lacked polymeric O antigen was not sensitive to polymyxin B or melittin. A...Continue Reading

References

Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D H Figurski, D R Helinski
Dec 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M E BayerH Goldfine
Feb 1, 1984·The Journal of Pediatrics·A IslesH Levison
May 1, 1997·Biological & Pharmaceutical Bulletin·S OieA Iwasaki
Feb 4, 1998·Antimicrobial Agents and Chemotherapy·H BrötzH G Sahl
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·W M ShaferR I Lehrer
Feb 3, 2000·Journal of Clinical Microbiology·E MahenthiralingamP Vandamme
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Dec 26, 2001·Journal of Bacteriology·Bernd KneidingerPaul Messner
Feb 5, 2002·Annual Review of Physiology·Brian C Schutte, Paul B McCray
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Aleksander PatrzykatRobert E W Hancock
Jun 22, 2002·Lancet·John J LiPumaCarlos F Gonzalez
Aug 6, 2002·The Journal of Antimicrobial Chemotherapy·Sazini NzulaJohn R W Govan
Apr 12, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuko Tsutsumi-Ishii, Isao Nagaoka
Jun 7, 2003·Journal of Clinical Microbiology·Tom CoenyeEshwar Mahenthiralingam
Mar 27, 2004·American Journal of Respiratory and Critical Care Medicine·Anthony De SoyzaRaquel Demarco de Hormaeche
Apr 6, 2004·FEMS Microbiology Letters·Sebastien FarnaudRobert W Evans
Jun 24, 2004·Infection and Immunity·Tracey A HuntMiguel A Valvano
Nov 24, 2004·Infection and Immunity·Miguel A CamposJosé A Bengoechea
Jan 12, 2005·Nature Reviews. Microbiology·Eshwar MahenthiralingamJoanna B Goldberg
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden

❮ Previous
Next ❯

Citations

Oct 27, 2010·BMC Genomics·Karlene H LynchJonathan J Dennis
Jul 17, 2010·PloS One·Josée Castonguay-VanierEric Déziel
May 25, 2013·Future Microbiology·Tony VelkovJian Li
Oct 22, 2008·Journal of Bacteriology·Matthew T G HoldenJulian Parkhill
Jul 21, 2010·Infection and Immunity·Slade A Loutet, Miguel A Valvano
Feb 16, 2011·Antimicrobial Agents and Chemotherapy·Agatha N JassemDavid P Speert
Aug 4, 2011·Frontiers in Microbiology·Slade A Loutet, Miguel A Valvano
Oct 19, 2011·Antimicrobial Agents and Chemotherapy·Rebecca J MalottDavid P Speert
Dec 29, 2013·Nature Genetics·Steve P BernierMichael G Surette
Feb 22, 2012·Canadian Journal of Microbiology·Karlene H Lynch, Jonathan J Dennis
May 1, 2015·Antibiotics·Victor I Band, David S Weiss
Jan 20, 2016·The Journal of General and Applied Microbiology·Seiji WakaoHiroshi Oyaizu
Jan 12, 2016·Biochimica Et Biophysica Acta·William F Walkenhorst
Apr 1, 2011·Environmental Microbiology Reports·Slade A LoutetMiguel A Valvano
Feb 24, 2015·Biochimica Et Biophysica Acta·Margaret E Bauer, William M Shafer
May 24, 2015·Biochimica Et Biophysica Acta·Yih-Ling Tzeng, David S Stephens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.